Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II...

Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA

MERMAID-2: Phase 3 study of durvalumab in patients with resected stage MRD II-III NSCLC ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )

Cemiplimab plus ipilimumab for advanced NSCLC

Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea

Cemiplimab plus ipilimumab for advanced NSCLC ( Prof Byoung Yong Shim - The Catholic University of Korea, Suwon, South Korea )

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small...

Dr Erminia Massarelli - City of Hope, Duarte, USA

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer ( Dr Erminia Massarelli - City of Hope, Duarte, USA )

Highlights from AORTIC Cancer Genomics Conference 2021

Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center...

Highlights from AORTIC Cancer Genomics Conference 2021 ( Dr Hannah Ayettey - National Radiotherapy Oncology and Nuclear Medicine Center, Accra, Ghana )

Incorporating KRAS as a novel biomarker: Challenges and opportunities

Prof Ales Ryska - Charles University, Prague, Czech Republic

Incorporating KRAS as a novel biomarker: Challenges and opportunities ( Prof Ales Ryska - Charles University, Prague, Czech Republic )

Real world data and diagnostics in patients with NSCLC with EGFR exon 20...

Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio...

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertions ( Prof Nicolas Girard, Prof Keith Kerr, Prof Frank Griesinger and Dr Antonio Passaro )

The Conquering Cancer Campaign

Prof Karen Canfell - University of Sydney, Sydney, Australia

The Conquering Cancer Campaign ( Prof Karen Canfell - University of Sydney, Sydney, Australia )

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC...

Prof Andrea Filippi - University of Pavia, Pavia, Italy

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )

ecancer special issue on medical education in Africa

Prof Cristina Stefan - SingHealth Duke-NUS Global Health Institute, Singapore

ecancer special issue on medical education in Africa ( Prof Cristina Stefan - SingHealth Duke-NUS Global Health Institute, Singapore )

Demographic, clinical and pathological characterisation of patients with...

Dr Carlos Selemane - Hospital Central de Maputo, Maputo, Mozambique

Demographic, clinical and pathological characterisation of patients with colorectal and anal cancer in Mozambique ( Dr Carlos Selemane - Hospital Central de Maputo, Maputo, Mozambique )

Cancer Genomics in Africa today

Dr Solomon Rotimi - Covenant University, Ota, Nigeria

Cancer Genomics in Africa today ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

More from ecancer